MedTrace Logo

Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size

NCT01398384 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2014-05-21

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of Nitric Oxide for Inhalation on Myocardial Infarction Size.

Conditions

  • Acute Myocardial Infarction

Interventions

DRUG

Nitric Oxide

MI size at 48-72 hours

DRUG

MI size at 48-72 hours

Placebo gas

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Stefan Janssens, Prof Dr · UZ Leuven

  • Frans Van de Werf, Prof Dr · UZ Leuven

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Belgium
  • Hungary
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01398384 on ClinicalTrials.gov